Codice QR

Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE

Abstract Introduction For chronic diseases such as axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and plaque psoriasis (PsO), treatment goals include remission or at least low disease activity (LDA) by 12 weeks. Improvements in symptoms such as pain and fatigue should also be treatment...

Descrizione completa

Salvato in:
Autori principali: Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Anja Plenske, Pascal Klaus, Thomas Meng
Natura: Artigo
Lingua:Inglês
Pubblicazione: Adis, Springer Healthcare 2024-02-01
Serie:Rheumatology and Therapy
Soggetti:
Axial spondyloarthritis
Etanercept
Plaque psoriasis
Psoriatic arthritis
Real world
Remission
Accesso online:https://doi.org/10.1007/s40744-023-00633-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi